Renal cell carcinoma as a metabolic disease: an update on main pathways, potential biomarkers, and therapeutic targets

NA di Meo, F Lasorsa, M Rutigliano, D Loizzo… - International Journal of …, 2022 - mdpi.com
Clear cell renal cell carcinoma (ccRCC) is the most frequent histological kidney cancer
subtype. Over the last decade, significant progress has been made in identifying the genetic …

The pathogenic role of PI3K/AKT pathway in cancer onset and drug resistance: an updated review

F Rascio, F Spadaccino, MT Rocchetti, G Castellano… - Cancers, 2021 - mdpi.com
Simple Summary Drug resistance remains one of the major problems in cancer therapy and
is responsible for up to 90% of cancer-related deaths. It exists across all types of cancer and …

Immune checkpoint inhibitors in renal cell carcinoma: molecular basis and rationale for their use in clinical practice

F Lasorsa, NA di Meo, M Rutigliano, M Milella, M Ferro… - Biomedicines, 2023 - mdpi.com
Renal cell carcinoma (RCC) is the seventh most common cancer in men and the ninth most
common cancer in women worldwide. There is plenty of evidence about the role of the …

The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery

NA di Meo, F Lasorsa, M Rutigliano… - Expert Review of …, 2023 - Taylor & Francis
Introduction Lipidomics focuses on the in-depth analysis of lipids, which are crucial
macromolecules involved in a wide range of metabolic pathways. The increased …

Cellular and molecular players in the tumor microenvironment of renal cell carcinoma

F Lasorsa, M Rutigliano, M Milella, M Ferro… - Journal of Clinical …, 2023 - mdpi.com
Globally, clear-cell renal cell carcinoma (ccRCC) represents the most prevalent type of
kidney cancer. Surgery plays a key role in the treatment of this cancer, although one third of …

MUC1 expression affects the immunoflogosis in renal cell carcinoma microenvironment through complement system activation and immune infiltrate modulation

G Lucarelli, GS Netti, M Rutigliano, F Lasorsa… - International Journal of …, 2023 - mdpi.com
Mucin1 (MUC1), a glycoprotein associated with an aggressive cancer phenotype and
chemoresistance, is aberrantly overexpressed in a subset of clear cell renal cell carcinoma …

Complement system and the kidney: its role in renal diseases, kidney transplantation and renal cell carcinoma

F Lasorsa, M Rutigliano, M Milella, M Ferro… - International Journal of …, 2023 - mdpi.com
The crosstalk among the complement system, immune cells, and mediators of inflammation
provides an efficient mechanism to protect the organism against infections and support the …

Complement system: promoter or suppressor of cancer progression?

M Revel, MV Daugan, C Sautés-Fridman, WH Fridman… - Antibodies, 2020 - mdpi.com
Constituent of innate immunity, complement is present in the tumor microenvironment. The
functions of complement include clearance of pathogens and maintenance of homeostasis …

Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma

G Lucarelli, M Ferro, D Loizzo, C Bianchi… - Metabolites, 2020 - mdpi.com
Clear cell renal cell carcinoma (ccRCC) is fundamentally a metabolic disease. Given the
importance of lipids in many cellular processes, in this study we delineated a lipidomic …

Complement C1s and C4d as prognostic biomarkers in renal cancer: emergence of noncanonical functions of C1s

MV Daugan, M Revel, J Russick… - Cancer Immunology …, 2021 - AACR
The complement system plays a complex role in cancer. In clear cell renal cell carcinoma
(ccRCC), local production of complement proteins drives tumor progression, but the …